PercayAI and Saint Louis University Partner to Accelerate AI Adoption across Biomedical Sciences Research
ST. LOUIS, Feb. 2, 2021 /PRNewswire/ --Biotech startup PercayAI and Saint Louis University (SLU) announced a partnership today to provide SLU researchers with access to PercayAI's augmented intelligence (AI) drug discovery platform.
- ST. LOUIS, Feb. 2, 2021 /PRNewswire/ --Biotech startup PercayAI and Saint Louis University (SLU) announced a partnership today to provide SLU researchers with access to PercayAI's augmented intelligence (AI) drug discovery platform.
- One of the primary components of the PercayAI platform is CompBio, software co-developed with the Genome Technology Access Center at the McDonnell Genome Institute (GTAC@MGI) at Washington University School of Medicine in St. Louis.
- "We're excited to establish a close partnership with Saint Louis University and work with them to support and expand the biological research community in Saint Louis."
- Founded in 1818, Saint Louis University is one of the nation's oldest and most prestigious Catholic institutions.